THE SMOOTH-MUSCLE ALPHA-ACTIN GENE PROMOTER IS DIFFERENTIALLY REGULATED IN SMOOTH-MUSCLE VERSUS NONSMOOTH MUSCLE-CELLS

被引:152
作者
SHIMIZU, RT [1 ]
BLANK, RS [1 ]
JERVIS, R [1 ]
LAWRENZSMITH, SC [1 ]
OWENS, GK [1 ]
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DEPT MOLEC PHYSIOL & BIOL PHYS,CHARLOTTESVILLE,VA 22908
关键词
D O I
10.1074/jbc.270.13.7631
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To identify potential regulators of smooth muscle cell (SMC) differentiation, we studied the molecular mechanisms that control the tissue-specific transcriptional expression of SM alpha-actin, the most abundant protein in fully differentiated SMCs. A construct containing the region from -1 to -125 of the promoter (p125CAT) had high transcriptional activity in SMCs (57-fold > promoterless) and endothelial cells (ECs) (18-fold) but not in skeletal myoblasts or myotubes. Mutation of either of two highly conserved CC(AT-rich)(6)GG (CArG) motifs at -62 and -112 abolished the activity of p125CAT in SMCs but had no effect in ECs. In contrast, high transcriptional activity in skeletal myotubes, which also express SM alpha-actin, required at least 271 base pairs of the promoter (-1 to greater than or equal to -271). Constructs containing 547 base pairs or more of the promoter were transcriptionally active in SMCs and skeletal myotubes but had no activity in skeletal myoblasts or ECs, cell types that do not express SM alpha-actin. Electrophoretic mobility shift assays provided evidence for binding of a unique serum response factor-containing complex of factors to the CArG box elements in SMCs. Results indicate that: 1) transcriptional expression of SM alpha-actin in SMCs requires the interaction of the CArG boxes with SMC nucleoprotein(s); 2) expression of SM alpha-actin in skeletal myotubes requires different cis-elements and trans-factors than in SMCs; and 3) negative-acting cis-elements are important in restricting transcription in cells that do not express SM alpha-actin.
引用
收藏
页码:7631 / 7643
页数:13
相关论文
共 85 条
  • [1] HUMAN SMOOTH-MUSCLE MYOSIN HEAVY-CHAIN ISOFORMS AS MOLECULAR MARKERS FOR VASCULAR DEVELOPMENT AND ATHEROSCLEROSIS
    AIKAWA, M
    SIVAM, PN
    KUROO, M
    KIMURA, K
    NAKAHARA, K
    TAKEWAKI, S
    UEDA, M
    YAMAGUCHI, H
    YAZAKI, Y
    PERIASAMY, M
    NAGAI, R
    [J]. CIRCULATION RESEARCH, 1993, 73 (06) : 1000 - 1012
  • [2] CARDIAC ACTIN IS THE MAJOR ACTIN GENE-PRODUCT IN SKELETAL-MUSCLE CELL-DIFFERENTIATION INVITRO
    BAINS, W
    PONTE, P
    BLAU, H
    KEDES, L
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1984, 4 (08) : 1449 - 1453
  • [3] BELKIN AM, 1988, J BIOL CHEM, V263, P6631
  • [4] BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
  • [5] DIFFERENCES AND SIMILARITIES IN DNA-BINDING PREFERENCES OF MYOD AND E2A PROTEIN COMPLEXES REVEALED BY BINDING-SITE SELECTION
    BLACKWELL, TK
    WEINTRAUB, H
    [J]. SCIENCE, 1990, 250 (4984) : 1104 - 1110
  • [6] BLANK RS, 1992, J BIOL CHEM, V267, P984
  • [7] THE SARCOMERIC ACTIN CARG-BINDING FACTOR IS INDISTINGUISHABLE FROM THE C-FOS SERUM RESPONSE FACTOR
    BOXER, LM
    PRYWES, R
    ROEDER, RG
    KEDES, L
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) : 515 - 522
  • [8] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [9] MYOGENIN RESIDES IN THE NUCLEUS AND ACQUIRES HIGH-AFFINITY FOR A CONSERVED ENHANCER ELEMENT ON HETERODIMERIZATION
    BRENNAN, TJ
    OLSON, EN
    [J]. GENES & DEVELOPMENT, 1990, 4 (04) : 582 - 595
  • [10] CARROLL SL, 1986, J BIOL CHEM, V261, P8965